The human myotubularin-related protein suppresses the growth of lung carcinoma cells

Oncology Reports

Volumn 12, Issue 3, 2004, Pages 667-671

  Yoo, Young Do ^a   Cho, Sun Mi ^a   Kim, Jun Suk ^a   Chang, Yoon Soo ^b   Ahn, Chul Min ^b   Kim, Hyung Jung ^b  

^a Korea University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Cell cycle arrest; Growth inhibition; Human myotubularin related protein; p27

Indexed keywords

CELL CYCLE PROTEIN; COMPLEMENTARY DNA; CYCLIN DEPENDENT KINASE INHIBITOR 1B; DNA; MTMR1 PROTEIN, HUMAN; PROTEIN TYROSINE PHOSPHATASE; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CELL CYCLE; CELL CYCLE G1 PHASE; CELL DIFFERENTIATION; CELL DIVISION; CELL SEPARATION; CHEMISTRY; DOSE RESPONSE; FLOW CYTOMETRY; GENE THERAPY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; IMMUNOBLOTTING; LUNG TUMOR; METABOLISM; METHODOLOGY; NORTHERN BLOTTING; PHYSIOLOGY; TREATMENT OUTCOME; TUMOR CELL LINE;

BLOTTING, NORTHERN; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIFFERENTIATION; CELL DIVISION; CELL LINE, TUMOR; CELL SEPARATION; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; G1 PHASE; GENE THERAPY; GENETIC VECTORS; HUMANS; IMMUNOBLOTTING; LUNG NEOPLASMS; PROTEIN-TYROSINE-PHOSPHATASE; TRANSFECTION; TREATMENT OUTCOME; TUMOR SUPPRESSOR PROTEINS;

EID: 7744226402     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.12.3.667     Document Type: Article

References (18)

1. Dyson N: The regulation of E2F by pRB-family proteins. Genes Dev 12: 2245-2262, 1998.
2. Zhu L, van den Heuvel S, Helin K, Fattaey A, Ewen M, Livingston D, Dyson N and Harlow E: Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 7: 1111-1125, 1993. (Pubitemid 23207404)
3. Claudio PP, Howard CM, Baldi A, De Luca A, Fu Y, Condorelli G, Sun Y, Colburn N, Calabretta B and Giordano A: p130/pRb2 has growth suppressive properties similar to yet distinctive from those of retinoblastoma family members pRb and p107. Cancer Res 54: 5556-5560, 1994. (Pubitemid 24346246)
4. Vogelstein B, Lane D and Levine AJ: Surfing the p53 network. Nature 408: 307-310, 2000.
5. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993. (Pubitemid 23346378)
6. Dammann R, Li C, Yoon JH, Chin PL, Bates S and Pfeifer GP: Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3. Nat Genet 25: 315-319, 2000. (Pubitemid 30437320)
7. Burbee DG, Forgacs E, Zochbauer-Muller S, Shivakumar L, Fong K, Gao B, Randle D, Virmani A, Bader S, Sekido Y, Latif F, Milchgrub S, Gazdar AF, Lerman MI, White MA and Minna JD: The RASSF1A locus in the 3p21.3 homozygous deletion region: epigenetic inactivation in lung and breast cancer and suppression of the malignant phenotype. Cancer Res 93: 691-699, 2001. (Pubitemid 32492810)
8. Shivakumar L, Minna J, Sakamaki T, Pestell R and White MA: The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol 22: 4309-4318, 2002. (Pubitemid 34556598)
9. Nagashima M, Shiseki M, Miura K, Hagiwara K, Linke SP, Pedeux R, Wang XW, Yokota J, Riabowol K and Harris CC: DNA damage-inducible gene p33ING2 negatively regulates cell proliferation through acetylation of p53. Proc Natl Acad Sci USA 98: 9671-9676, 2001. (Pubitemid 32769361)
10. Garkavtsev I, Grigorian IA, Ossovskaya VS, Chernov MV, Chumakov PM and Gudkov AV: The candidate tumour suppressor p33ING1 cooperates with p53 in cell growth control. Nature 391: 295-298, 1998. (Pubitemid 28099018)
11. Versteege I, Medjkane S, Rouillard D and Delattre O: A key role of the hSNF5/INI1 tumour suppressor in the control of the Gl-S transition of the cell cycle. Oncogene 21: 6403-6412, 2002. (Pubitemid 35155445)
12. Yarden RI, Pardo-Reoyo S, Sgagias M, Cowan KH and Brody LC: BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet 30: 285-289, 2002.
13. Taylor GS, Maehama T and Dixon JE: Myotubularin, a protein tyrosine phosphatase mutated in myotubular myopathy, dephosphorylates the lipid second messenger, phosphatidylinositol 3-phosphate. Proc Natl Acad Sci USA 97: 8910-8915, 2000. (Pubitemid 30626647)
14. Hunter T and Pines J: Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79: 573-582, 1994. (Pubitemid 24363801)
15. Tomizawa Y, Sekido Y, Kondo M, Gao B, Yokota J, Roche J, Drabkin H, Lerman MI, Gazdar AF and Minna JD: Inhibition of lung cancer cell growth and induction of apoptosis after re-expression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl Acad Sci USA 98: 13954-13959, 2001. (Pubitemid 33116005)
16. Dumont P, Leu JI, Della Pietra AC III, George DL and Murphy M: The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33: 357-365, 2003. (Pubitemid 36278852)
17. Dulic V, Kaufmann WK, Wilson SJ, Tlsty TD, Lees E, Harper JW, Elledge SJ and Reed SI: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76: 1013-1024, 1994.
18. Yoo YD, Choi JY, Lee SJ, Kim JS, Min BR, Lee YI and Kang YK: TGF-beta-induced cell-cycle arrest through the p21(WAF1/CIP1)-G1 cyclin/Cdks-p130 pathway in gastric-carcinoma cells. Int J Cancer 83: 512-517, 1999. (Pubitemid 29489867)